Grants decrease by 39% this week, 23480 patent applications granted till date

This week’s Indian patent statistics indicate a 39 percent decline in grants, bringing the cumulative total to 23480. The report provides an analytical overview of patent publications, examinations, and design registrations across key Indian cities.

Read more about Grants decrease by 39% this week, 23480 patent applications granted till date

Annual report 2018-2019 published, US and EU block India and South Africa on IPR waiver proposal and more

The Annual Report 2018-2019 from the Office of CGPDTM highlights growth in Indian IPR filings and introduces new initiatives. The post also addresses international opposition to India’s TRIPS IPR waiver proposal and recent updates in the patent landscape.

Read more about Annual report 2018-2019 published, US and EU block India and South Africa on IPR waiver proposal and more

NAIMCC acquires status of International Depository Authority under the Budapest Treaty and other patent news

NAIMCC has become an International Depository Authority under the Budapest Treaty, as announced by the Indian Patent Office and WIPO. This update also covers key statements from the BRICS Trade Ministers meeting and major international IP developments.

Read more about NAIMCC acquires status of International Depository Authority under the Budapest Treaty and other patent news

WIPO PROOF – a new service from WIPO, High Court orders withdrawal of IPOs public notice and other patent news

WIPO PROOF has been introduced as a digital evidence service for intellectual assets. The Delhi High Court has withdrawn a key IPO notice, impacting patent timelines. This update also covers patent litigation and international patent infrastructure developments.

Read more about WIPO PROOF – a new service from WIPO, High Court orders withdrawal of IPOs public notice and other patent news

COVID-19 patent pool opposed as Pfizer and AstraZeneca see no incentive and other patent news

This bulletin provides updates on the COVID-19 patent pool, opposition from leading pharmaceutical companies, and key patent law changes in India and abroad. It includes IPO e-filing developments, WHO C-TAP news, and significant international patent infringement cases.

Read more about COVID-19 patent pool opposed as Pfizer and AstraZeneca see no incentive and other patent news